Xponance, Inc. Vbi Vaccines Inc Transaction History

Xponance, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 23, 2023	BUY	$0.38 - $22.5 $30 - $1,800	80 Added 0.75%	10,712 $0
Q3 2022 Oct 24, 2022	BUY	$0.73 - $23.4 $203 - $6,528	279 Added 2.69%	10,632 $8,000
Q2 2022 Aug 02, 2022	BUY	$0.66 - $1.81 $6,832 - $18,738	10,353 New	10,353 $8,000
Q3 2021 Nov 05, 2021	SELL	$2.8 - $3.72 $28,534 - $37,910	-10,191 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$2.61 - $4.17 $26,598 - $42,496	10,191 New	10,191 $34,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Xponance, Inc., based on Form 13F filings with the SEC.

Stay updated on Xponance, Inc. with notifications on news.